Wild-Type ATTR Cardiac Amyloidosis Clinical Trials Near Me
As of October 12, 2026, 9 Wild-Type ATTR Cardiac Amyloidosis clinical trials are recruiting. 2 of them have at least 1 open site in the United States, across 21 states. Enter your ZIP code to see which are closest to you.
Also on Trial Friend:Wild-Type ATTR Cardiac Amyloidosis pageMatch Me
All 9 Wild-Type ATTR Cardiac Amyloidosis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis33 open sitesRecruitingAges 18 to 130Run by AstraZeneca
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac AmyloidosisCedars-Sinai Medical Center, Beverly Hills, California; Tufts Medical Center, Boston, Massachusetts; Boston Medical Center, Boston, Massachusetts and 2 more sitesRecruitingAges 50+Run by Columbia University
- A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.No open US site listed yetRecruitingAges 18+Run by Medical University of Vienna
- A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world SettingNo open US site listed yetRecruitingAges 18+Run by Bayer
- A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to AcoramidisNo open US site listed yetRecruitingPhase 4Ages 18 to 90Run by Bayer
- ATTR Cardiac Amyloidosis in a Selected PopulationNo open US site listed yetRecruitingAges 50+Run by Helse Møre og Romsdal HF
- Liver and Coagulation Disorders in Cardiac Transthyretin AmyloidosisNo open US site listed yetRecruitingAges 18+Run by University of Messina
- Phenotyping and Characterization of wtATTR-CM (TRACE 1)No open US site listed yetRecruitingAges 18+Run by Steen Hvitfeldt Poulsen
- Study of Acoramidis in Patients With Transthyretin Amyloid CardiomyopathyNo open US site listed yetRecruitingAges 18+Run by Bayer
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Wild-Type ATTR Cardiac Amyloidosis. Turn any of these off from the link in every email.
Where Wild-Type ATTR Cardiac Amyloidosis trials are recruiting in the US
The US cities with the most Wild-Type ATTR Cardiac Amyloidosis trials recruiting are Boston, Massachusetts (2), New York, New York (2), Baltimore, Maryland (1), Beverly Hills, California (1) and Chicago, Illinois (1), counting trials with at least 1 open site in each city.
Hospitals that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Wild-Type ATTR Cardiac Amyloidosis, even if no trial fits you.
- Boston Medical Center
- Tufts Medical Center
- Columbia University Irving Medical Center
- Cedars-Sinai Medical Center
- Cleveland Clinic
States with at least 1 open site: California, Connecticut, District of Columbia, Illinois, Indiana, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin.
Questions about finding a Wild-Type ATTR Cardiac Amyloidosis trial near you
Are there Wild-Type ATTR Cardiac Amyloidosis clinical trials near me?
As of October 12, 2026, 9 Wild-Type ATTR Cardiac Amyloidosis clinical trials are recruiting. 2 of them have at least 1 open site in the United States, across 21 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Wild-Type ATTR Cardiac Amyloidosis clinical trial sites?
As of October 12, 2026, recruiting Wild-Type ATTR Cardiac Amyloidosis trials list open sites in 21 states. The US cities with the most Wild-Type ATTR Cardiac Amyloidosis trials recruiting are Boston, Massachusetts (2), New York, New York (2), Baltimore, Maryland (1), Beverly Hills, California (1) and Chicago, Illinois (1), counting trials with at least 1 open site in each city.
What if there is no Wild-Type ATTR Cardiac Amyloidosis trial near me?
Some trials pay for or reimburse travel and lodging, and a few send staff or use local labs so fewer visits happen at the study site, so ask the study contact before ruling a trial out. You can also sign up on this page to get an email when a Wild-Type ATTR Cardiac Amyloidosis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Wild-Type ATTR Cardiac Amyloidosis: Amvuttra (vutrisiran), Vyndamax (tafamidis), Attruby (acoramidis).
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of October 12, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out.